AGT and cardiac hypertrophy: Thus, in one study, osteopontin deficiency attenuated cardiac hypertrophy induced by Ang-II infusion [59], whereas, in another study, osteopontin deletion did not prevent cardiac hypertrophy, despite attenuated myocardial fibrosis [29].